Archer Materials Limited () chief executive officer Dr Mohammad Choucair updates Proactive on the filing of an international patent application to commercialise the company’s ground-breaking graphene biosensor technology and protect its international property.
Archer is a leader in developing technology for the use of graphene materials for human health, which could provide potential solutions, for example, to rapid, highly sensitive and portable testing for in-vitro diagnostics.
The company’s biosensor technology is unique in that it uses digital manufacturing to print critical ultrasensitive graphene material components that are integrated into one of a number of sensors.
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is…
In exchange for publishing services rendered by the Company on behalf of Archer Materials Ltd named herein, including the promotion by the Company of Archer Materials Ltd in any Content on the Site, the Company…
This is a syndicated post. Read the original post at Source link .